Philippe Mauberna
Director/Board Member at Impulse Consulting Ltd.
Network origin in Philippe Mauberna first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
16
| Public Company | Medical Specialties | 16 |
Capgemini Consulting SAS
 Capgemini Consulting SAS Miscellaneous Commercial ServicesCommercial Services Capgemini Consulting SAS provides management consulting and outsourcing services. The firm advises and supports organizations in transforming their business. The company was founded on July 12, 2004 and is headquartered in Paris, France.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Philippe Mauberna via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Medical Specialties | Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Imperial Chemical Industries Ltd.
 Imperial Chemical Industries Ltd. Chemicals: Major DiversifiedProcess Industries Imperial Chemical Industries Ltd. manufactures chemicals and paint products. Its products include coatings, adhesives, starch, and synthetic polymer. The company was founded on December 7, 1926 and is headquartered in Slough, the United Kingdom. | Chemicals: Major Diversified | Corporate Officer/Principal | |
| George Washington University | College/University | Undergraduate Degree | |
Zeneca Garden Care
 Zeneca Garden Care Pharmaceuticals: OtherHealth Technology Part of AstraZeneca PLC, Zeneca Garden Care is a British company that develops and manufactures pharmaceutical products, agrochemicals, and specialty chemicals. The private company is based in Macclesfield, UK. Zeneca Garden Care was acquired by Zeneca Group Plc on January 01, 1995 for $84.16 million. | Pharmaceuticals: Other | Corporate Officer/Principal | |
| Ecole Nationale des Ponts et Chaussées | College/University | Corporate Officer/Principal | |
J.C. Flowers & Co. LLC
 J.C. Flowers & Co. LLC Investment ManagersFinance J.C. Flowers & Co. LLC (J.C. Flowers & Co.) is a private equity firm founded in 1998 by J. Christopher Flowers. The firm is headquartered in New York. | Investment Managers | Private Equity Analyst | |
Fordham University
 Fordham University Other Consumer ServicesConsumer Services Fordham University provides college and university. It offers undergraduate colleges and graduate & professional schools. The company was founded in 1841 and is headquartered in Bronx, NY. | College/University | Masters Business Admin | |
| INSEAD | College/University | Masters Business Admin | |
| Technische Universität München | College/University | Doctorate Degree | |
| HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
MSD Vaccines Ltd.
 MSD Vaccines Ltd. Pharmaceuticals: OtherHealth Technology MSD Vaccines Ltd. manufactures and supplies vaccines. Its main way of achieving this goal is to develop and make available innovative vaccines against a wide spectrum of diseases. It also dedicated to increasing the understanding of the value of vaccines and vaccination by providing relevant and accurate information on their quality, safety and efficacy. The company was founded in 1975 and is headquartered in Maidenhead, the United Kingdom. | Pharmaceuticals: Other | Director/Board Member | |
| University of Leiden | College/University | Graduate Degree | |
Institut Mines-Télécom
 Institut Mines-Télécom Miscellaneous Commercial ServicesCommercial Services Institut Mines-Télécom provides information technology education services. It is an organization for higher education and research in the information and communication technologies and sciences. The firm also provides information technology education services. The company was founded in 1844 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member | |
| Sciences Po | College/University | Undergraduate Degree | |
| ESSEC Business School | College/University | Masters Business Admin | |
| École Normale Supérieure | College/University | Doctorate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Graduate Degree | |
| Institut Supérieur d'Electronique de Paris | College/University | Director/Board Member | |
| SARTORIUS STEDIM BIOTECH | Medical Specialties | Director/Board Member | |
| Sanofi España SA | Director/Board Member | ||
| Sanofi Pasteur MSD SA | Corporate Officer/Principal | ||
AIG Global Investment Group, Inc.
 AIG Global Investment Group, Inc. Investment ManagersFinance Part of American International Group, Inc., AIG Global Investment Group, Inc. provides investment advisory services. The private company is based in New York, NY. The CEO of the company is Win Jay Neuger. | Investment Managers | Corporate Officer/Principal | |
AXA Partners Holdings Ltd.
 AXA Partners Holdings Ltd. Multi-Line InsuranceFinance AXA Partners Holdings Ltd. provides accident, sickness, and unemployment insurance services. The company was founded on September 29, 2003 and is headquartered in London, the United Kingdom. | Multi-Line Insurance | Human Resources Officer | |
Themis Bioscience GmbH
 Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member | |
| Pharma-Lizenz-Club Deutschland | Corporate Officer/Principal | ||
| Olin Business School | College/University | Masters Business Admin | |
| Pharma Licensing Club France | Corporate Officer/Principal | ||
| EUROBIO SCIENTIFIC | Medical Specialties | Chairman | |
| VALNEVA | Biotechnology | Chairman | |
| Axa Research Fund | Founder | ||
Sanofi Pasteur MSD Ltd. (Ireland)
 Sanofi Pasteur MSD Ltd. (Ireland) BiotechnologyHealth Technology Part of Merck & Co., Inc., Sanofi Pasteur MSD Ltd. is a private company based in Dublin, Ireland. The Irish company develops and produces vaccines. | Biotechnology | Director/Board Member | |
Sanofi Pasteur MSD SA (Spain)
 Sanofi Pasteur MSD SA (Spain) Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Sanofi Pasteur MSD SA is a private company based in Madrid, Spain. The Spanish company develops vaccines. | Pharmaceuticals: Major | Director/Board Member | |
| Smag Consulting SARL | Chief Executive Officer | ||
| PROMETHEUS BIOSCIENCES, INC. | Biotechnology | Investor Relations Contact | |
Roc SA
 Roc SA Real Estate DevelopmentFinance Roc SA provides housing development services. | Real Estate Development | Corporate Officer/Principal | |
Servier Pharmaceuticals LLC
 Servier Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Servier SAS, Servier Pharmaceuticals LLC is a privately held pharmaceutical company focused on oncology. The company is based in Boston, MA. Servier Pharmaceuticals continues to build a treatment portfolio with a current focus on oncology within acute lymphoblastic leukemia. The company invests in innovative research and development through development or partnerships to best address the unmet needs of patients. Additionally, the company is proud to offer financial assistance to not only support patients and their families but a variety of focused advocacy groups and healthcare professionals as well. Servier Pharmaceuticals is committed to engaging with patients, caregivers, families, and patient organizations to ensure their voices are heard in every initiative. The company's responsibility is to help make the world a better place for patients and their families, and it strives to have consistent and concise transparency throughout all clinical trials and research and development for the benefit of all patients. The company was founded in 1954. The CEO is David K. Lee. | Pharmaceuticals: Major | Director of Finance/CFO | |
| ONCTERNAL THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| BIOMX INC. | Biotechnology | Investor Relations Contact | |
| Ici Pharma | Chief Executive Officer | ||
M2care SAS
 M2care SAS Miscellaneous Commercial ServicesCommercial Services M2care SAS is a French healthcare company founded in 2017. The company is based in Lyon, France. M2care is a team of passionate entrepreneurs who invest in human and financial value to co-found, co-operate, and co-develop innovative projects in the healthcare sector until they reach the patient. | Miscellaneous Commercial Services | Director/Board Member | |
Fight Cancer Global, Llc
 Fight Cancer Global, Llc Information Technology ServicesTechnology Services Fight Cancer Global, LLC provides a network platform aimed at solving the isolation problems faced by cancer patients. The private company is based in Houston, TX. | Information Technology Services | Director/Board Member | |
| APOGEE THERAPEUTICS, INC. | Biotechnology | Investor Relations Contact | |
| New York University School of Medicine | College/University | Doctorate Degree | |
Innocrin Pharmaceuticals, Inc.
 Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistics
International
| France | 19 |
| United States | 15 |
| United Kingdom | 8 |
| Germany | 4 |
| Spain | 3 |
Sectoral
| Health Technology | 18 |
| Consumer Services | 15 |
| Finance | 7 |
| Technology Services | 3 |
| Commercial Services | 3 |
Operational
| Corporate Officer/Principal | 52 |
| Director/Board Member | 37 |
| Independent Dir/Board Member | 10 |
| Chairman | 9 |
| Chief Executive Officer | 9 |
Most connected contacts
| Insiders | |
|---|---|
| Anne-Marie Graffin | 22 |
| Gary Phillips | 20 |
| Jérôme Snollaerts | 15 |
| Christophe Douat | 13 |
| Enno Spillner | 13 |
| Laurent Condomine | 11 |
| Rick A. Winegar | 10 |
| Anne-Juliette Hermant | 9 |
| Noël Kurdi | 9 |
| Edwina Baskin-Bey | 7 |
| Alain Dostie | 6 |
| Bernd Mühlenweg | 5 |
| Elsa Borghi | 5 |
| Bart van Rhijn | 5 |
| Patrick Tricoli | 2 |
- Stock Market
- Insiders
- Philippe Mauberna
- Company connections
